Loading insider details...
Beta
Latest Form 4 (Jan 8, 2026): Sale of 10,591 RNAC shares, $72.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 8, 2026 | Cartesian Therapeutics, Inc. (RNAC) | Sale | 10,591 | $72.2K |
| Jan 6, 2026 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 37,000 | n/a |
| Jan 8, 2025 | Cartesian Therapeutics, Inc. (RNAC) | Sale | 3,961 | $66.2K |
| Jan 6, 2025 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 22,000 | n/a |
| Jan 4, 2024 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 2,424,000 | n/a |
| Nov 15, 2023 | Cartesian Therapeutics, Inc. (RNAC) | Disposition to Issuer | 1,250,000 | $987.5K |
| Nov 30, 2022 | SELECTA BIOSCIENCES INC (SELB) | Grant/Award | 1,250,000 | n/a |
| Jul 19, 2022 | Protara Therapeutics, Inc. (TARA) | Tax Withholding | 5,081 | $15.9K |
| Jan 5, 2022 | Protara Therapeutics, Inc. (TARA) | Grant/Award | 14,100 | n/a |
| Jan 21, 2021 | Protara Therapeutics, Inc. (TARA) | Grant/Award | 75,000 | n/a |